Levetiracetam Sandoz (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilizing neuronal firing and decreasing excessive excitability, it lowers the likelihood of seizure initiation and spread throughout the brain.

The specific dose of Levetiracetam Sandoz is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing individuals. Consultation with a specialist is recommended.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It is often favored for its relatively favorable drug‑interaction profile and ease of dosing, though individual response varies.

Store Levetiracetam Sandoz tablets at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight to maintain potency.

Levetiracetam Sandoz is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically advised.

Serious risks include severe allergic reactions (rash, swelling, breathing difficulty), psychiatric effects such as depression or suicidal thoughts, and rare blood disorders like leukopenia. Patients should seek immediate medical attention if any of these occur.

Individuals with known hypersensitivity to levetiracetam or any of its excipients should avoid the medication. Caution is also advised for patients with severe renal impairment, as dose adjustments may be required.